MILLIGAN MICHAEL LEE (See Remarks) sold 8.1% of their position (1.98K shares) of NEUMORA THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.4K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2025ACC: 0001610717-25-000030
Officer· See Remarks
Since Feb 2026
-1.98K
Net shares
Net seller
$3.4K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.98K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.98K
Price / share
$1.69
Trade value
$3.35K
% of position
8.1%
2/18/2025
24.45K→22.47K
Total
Net shares
−1.98K
Net value
-$3.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2025 | S · Sale | −1.98K | $1.69 | $3.35K | 8.1% | 24.45K | 22.47K |
| Total | −1.98K | -$3.35K | ||||||
Derivative Transactions0
No derivative transactions reported